… and policy in the European Union. Based on this definition, the regulatory bodies have …
Sometimes, the biological framework is the base for the regulation of the NBCDs, because …

… The difference between nanomedicine and conventional drugs is that nanomedicine is
entirely … In sum, the experience on the safety use of nanomedicine is still very limited seen from …

… Incorporating nanomedicine regulation into the current regulatory scheme is a poor idea.
Regulation of nanomedicine must balance innovation and R&D with the principle of ensuring …

… FDA, and part four will discuss the consequences of the FDA's … of the regulatory challenges
posed by nanomedicine, highlights what the FDA has done to address these issues in the …

… the end of the beginning which will guide nanomedicine into a new, more mature phase? To
answer this question, we propose to first proceed as described in the … tell investors the truth …

… briefly summarizes the promise of nanomedicine as well as … attempts to harmonize regulatory
requirements at the international level. … harmonization in the regulation of nanomedicine. …

… the emerging field of nanomedicine and then proceeds to detail the current regulatory framework
and regulatory … article highlights the fact that with the advancement of nanomedicine the …

… potential regulatory issues that such applications may give rise to, the … regulation and opacity
in the field of nanomedicine that this article explores. It does so by first tracing the regulatory …

… Despite the great need for a formal regulatory document, the FDA continues to ignore … they
are taking a precautionary approach to the regulation of Nanomedicine, perhaps in hope to …

… for the regulation of nanomedicines, discussing the efforts under development by industry and
regulatory agencies to promote their translation into the … , the first approved nanomedicine …